Reactions to Sermo-Pfizer partnership

This item was filled under [ ]

As some of you may know, Sermo, a private social network of 30,000 US physicians online announced a deal this week with Pfizer that allows the company’s medical staff access to the community and the ability to interact with members. It is being met with mixed reactions. Many doctors that belong to the site valued the security of peer-based interactions. Throwing a “marketer” into the mix poses some real challenges. Here are some links to recent coverage.

Original AP story
Pfizer Joins Online Doctors’ Forum

Prominent reactions and analysis

WSJ Online – Pfizer-Doctors Web Pact May Get Looks
WSJ Health Blog (includes video commentary) – Sermo Access Primo for Pfizer, But Will It Be Welcome?
MSNBC – Pfizer takes a leaf out of Facebook
HealthcareVOX – As Sermo & Pfizer Link Up, Some Worry About Off-Label Marketing
Pharma Marketing – Pfizer Has Gold Mine in Sermo
Pharmalot – Docs On Sermo-Pfizer Deal: ‘You Let The Enemy In’
[tags]pfizer, sermo, social networking, healthcare, pharma[/tags]